Cutaneous effects with imatinib (Glivec®);Effets secondaires cutanés de l'imatinib (Glivec®)

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 5, 2004, Pages 517-518

  Schmutz, J L ^a   Barbaud, A ^a   Trechot, P ^b  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; METRONIDAZOLE; TERBINAFINE;

CHRONIC MYELOID LEUKEMIA; DIARRHEA; DOSE RESPONSE; DRUG MECHANISM; DYSPEPSIA; EDEMA; FATIGUE; GASTROINTESTINAL TUMOR; HEADACHE; HUMAN; LICHENOID ERUPTION; LIVER DYSFUNCTION; MYALGIA; NAUSEA; PIGMENT DISORDER; PITYRIASIS ROSEA; SHORT SURVEY; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME;

EID: 2942722374     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93656-3     Document Type: Short Survey

References (5)

1. Esmaeli B, Prieto VG, Butler CE, Kin, SK, Ahmadi MA, Kantartian HM et al. Severe periorbital edema secondary to STI571 (Gleevec). Cancer 2002;95:881-7.
2. Hsiao LT, Chung HM, Lin JT, Chiou TJ, Liu JH, Fan FS et al. Stevens-Johnson syndrome after treatment with STI571: a case report. Br J Haematol 2002;117:620-2.
3. Konstantopoulos K, Papadogianni A, Dimopoulou M, Kourelis C, Meletis J. Pityriasis rosea associated with imatinib (STI 571, Gleevec). Dermatology 2002;205:172-3.
4. Lim DS, Muir J. Oral lichenoid reaction to imatinib (STI 571, Gleevec). Dermatology 2002; 205:169-71.
5. Etienne G, Cony-Makhoul P, Mahon FX. Imatinib mesylate and gray hair. N Engl J Med 2002;347:446.